Actinic keratosis often referred to as solar keratosis or senile keratosis is a common skin condition caused by prolonged exposure to ultraviolet (UV) radiation, primarily from the sun. It manifests as rough, scaly patches or lesions on the skin and is considered a precursor to skin cancer. Johns Hopkins Medicine states that Actinic Keratosis is not life-threatening.

Platforms like Medditour connect the patients seeking treatments for actinic keratosis with the international hospitals and facilitators for cost-effective treatments.
This article explores the diagnosis and treatment of actinic keratosis, as well as the potential for medical tourism in India, Malaysia, and Singapore to offer access to high-quality dermatological care.
Diagnosis of Actinic Keratosis
Actinic keratosis diagnosis typically involves a thorough examination by a dermatologist.

- Visual Inspection: The dermatologist examines the skin for signs of actinic keratosis. These can include dry, rough, or scaly patches, as well as red or pink lesions that may feel tender or itchy.

- Dermoscopy: In some cases, dermoscopy, a non-invasive technique that uses a special magnifying lens and light, may be used to examine skin lesions more closely. This can help distinguish actinic keratosis from other skin conditions.

- Biopsy: If there is uncertainty about the diagnosis or if the dermatologist suspects skin cancer, a biopsy may be performed. During a biopsy, a small sample of the affected skin is removed and sent to a laboratory for examination. Cleveland Clinic states that about 90% of people with actinic keratosis don’t develop skin cancer.
Treatment Options for Actinic Keratosis
Common treatment modalities include:

- Topical Medications: Topical treatments, such as creams or gels containing ingredients like imiquimod, fluorouracil (5-FU), or diclofenac, are applied directly to the affected areas.

- Cryotherapy: Cryotherapy, or freezing, involves applying liquid nitrogen to the affected areas. This freezes and destroys the abnormal skin cells, causing the lesions to peel off as the skin heals.

- Photodynamic Therapy (PDT): PDT combines the application of a photosensitizing agent with exposure to a specific wavelength of light. This treatment selectively targets and destroys actinic keratosis lesions.

- Curettage and Electrodessication: In this procedure, the dermatologist scrapes away the surface of the lesion with a curette and then uses an electric current (electrodessication) to destroy any remaining abnormal cells.

- Laser Therapy: Laser therapy employs intense light energy to target and remove actinic keratosis lesions.
Medical Tourism for Actinic Keratosis

India, Malaysia, and Singapore have become prominent destinations for medical tourism due to their advanced healthcare infrastructure, skilled dermatologists, and cost-effective healthcare services.
India boasts state-of-the-art medical facilities and highly trained dermatologists. The cost of actinic keratosis treatments in India is significantly lower than in many Western countries, making it an affordable option for international patients.
Malaysia is known for its modern healthcare system and proficient dermatologists. The country offers competitive prices for dermatological treatments, making it an economically attractive choice for medical tourists.
Singapore is renowned for its world-class healthcare infrastructure and experienced dermatologists. While the cost of treatment may be higher than in some other medical tourism destinations, the quality of care is exceptional.
Medical tourism companies like Medditour provide opportunities for patients seeking treatments for actinic keratosis to combine their treatments with vacation.
In conclusion, actinic keratosis is a common skin condition that requires timely diagnosis and treatment to prevent its progression into skin cancer. Medical tourism in countries like India, Malaysia, and Singapore offers an opportunity for individuals to access high-quality dermatological care for actinic keratosis while benefiting from cost-effective healthcare.